Login / Signup
Hai-Feng Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 9
Top Topics
Disease Activity
High Dose
Myasthenia Gravis
Top Venues
European journal of neurology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hai-Feng Li
,
Zuneng Lu
Possible benefit of second intravenous immunoglobulin course in Guillain-Barré syndrome patients with potentially poor prognosis.
European journal of neurology
31 (4) (2024)
Hai-Feng Li
,
Zuneng Lu
Possible benefit of second intravenous immunoglobulin course in Guillain-Barré syndrome patients with potentially poor prognosis.
European journal of neurology
31 (4) (2024)
Hai-Feng Li
,
Zuneng Lu
Possible benefit of second intravenous immunoglobulin course in Guillain-Barré syndrome patients with potentially poor prognosis.
European journal of neurology
31 (4) (2024)
Hai-Feng Li
,
Zuneng Lu
Possible benefit of second intravenous immunoglobulin course in Guillain-Barré syndrome patients with potentially poor prognosis.
European journal of neurology
(2024)
Hai-Feng Li
,
Feng Gao
,
Xiang-Jun Chen
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis.
European journal of neurology
30 (4) (2023)
Hai-Feng Li
,
Feng Gao
,
Xiang-Jun Chen
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis.
European journal of neurology
30 (4) (2023)
Hai-Feng Li
,
Feng Gao
,
Xiang-Jun Chen
Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis.
European journal of neurology
(2023)
Hai-Feng Li
,
Feng Gao
,
Xiang-Jun Chen
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis.
European journal of neurology
(2023)
Hai-Feng Li
,
Feng Gao
,
Xiang-Jun Chen
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis.
European journal of neurology
30 (4) (2023)